Cipremi: Cipla launches 100 mg antiviral drug to treat severe Covid-19 patient, all you need to know

New Delhi, June 22: Cipla, an Indian multinational pharmaceutical and biotechnology company, has launched its own 100 mg antiviral drug named Cipremi for treating severe COVID-19 patients. 'Cipremi', a drug for COVID-19 infection, has been approved for adult and

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/3fLIZ83

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post